- Home
- API vs TKNO Comparison
API vs TKNO Comparison
Compare API & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- TKNO
- Stock Information
- Founded
- API 2013
- TKNO 1996
- Country
- API United States
- TKNO United States
- Employees
- API N/A
- TKNO N/A
- Industry
- API Computer Software: Prepackaged Software
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- API Technology
- TKNO Health Care
- Exchange
- API Nasdaq
- TKNO Nasdaq
- Market Cap
- API 343.2M
- TKNO 256.9M
- IPO Year
- API 2020
- TKNO 2021
- Fundamental
- Price
- API $3.45
- TKNO $4.35
- Analyst Decision
- API Strong Buy
- TKNO
- Analyst Count
- API 1
- TKNO 0
- Target Price
- API $6.00
- TKNO N/A
- AVG Volume (30 Days)
- API 508.9K
- TKNO 224.0K
- Earning Date
- API 08-18-2025
- TKNO 08-07-2025
- Dividend Yield
- API N/A
- TKNO N/A
- EPS Growth
- API N/A
- TKNO N/A
- EPS
- API N/A
- TKNO N/A
- Revenue
- API $133,554,000.00
- TKNO $38,923,000.00
- Revenue This Year
- API $7.20
- TKNO $9.52
- Revenue Next Year
- API $11.26
- TKNO $15.20
- P/E Ratio
- API N/A
- TKNO N/A
- Revenue Growth
- API N/A
- TKNO 11.40
- 52 Week Low
- API $1.78
- TKNO $4.00
- 52 Week High
- API $6.99
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- API 40.21
- TKNO 43.35
- Support Level
- API $3.48
- TKNO $4.22
- Resistance Level
- API $3.67
- TKNO $4.94
- Average True Range (ATR)
- API 0.19
- TKNO 0.29
- MACD
- API -0.02
- TKNO -0.00
- Stochastic Oscillator
- API 10.17
- TKNO 16.75
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.